Antimicrobial resistance in developing countries. Part I: recent trends and current status.

By I. Okeke, Ramanan Laxminarayan, Z. Bhutta, Adriano G. Dusé, P. Jenkins, T. O'Brien, A. Pablos-Mendez, K. Klugman. Lancet. Infectious Diseases (Print), 2005

919 citations recorded by the source corpus.

Subfields: Applied Microbiology and Biotechnology, Epidemiology, Molecular Medicine

View Paper: https://www.semanticscholar.org/paper/622888a692a4b4293e7dd962f4b2f8e75e2ac778

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Applied Microbiology and Biotechnology

1. J. Guil-Guerrero
2. M. Carlosama-Yepez
3. J. C. Zúñiga-Paredes
4. C. Moreno
5. Luis A. Ramos
6. P. Ruales

In Molecular Medicine

1. Jay P. Graham
2. E. Silbergeld
3. L. Price

Citations in the corpus

• Antimicrobial activity of plant-food by-products: A review focusing on the tropics (2016, background): “…this problem is the abusive veterinary use of antibiotics, which occurs mainly for preventive purposes, with the result that antibiotic residues appear in the environment, indicating the excessive use in animal-production farms (Farrar, 1985; Hart and Kariuki, 1998; Okeke et al., 2005, 1999).”
• Point-of-care diagnostics for global health. (2008, background): “Drug resistance has become a major concern in the management of malaria, TB, HIV, and bacterial infections (74–78) and already places a significant health and cost burden on developing countries (76, 79).”
• The threat of antimicrobial resistance in developing countries: causes and control strategies (2017, background): “Non-compliance in the use of antimicrobials has many repercussions upon resistance and poverty is a major root factor of antimicrobial misuse in developing countries [4].”
• Industrial food animal production, antimicrobial resistance, and human health. (2008, background): “Antimicrobial-resistant bacterial infections now account for many emerging infectious diseases worldwide (17, 54).”
• Has the era of untreatable infections arrived? (2009, neutral): “IMP .64 8 (2) 0.125 4 .256 (16) � 0.125 41 6.32 16 � 0.5 E. coli IMP .64 8 ( 2 ) 0.125 (2) 256 (8) 0.25 .8 .32 .32 2 � 0.5 Enterobacter spp.”